Influenza vaccination coverage rates insufficient across EU Member States
None of the European Union (EU) Member States could demonstrate that they reach the EU target of 75% influenza vaccination coverage for vulnerable groups, according to a new report from the European Centre for Disease Prevention and Control (ECDC).
Expert panel reviews neuraminidase inhibitors for the prevention and treatment of influenza
An ECDC expert opinion concludes that there is clear evidence supporting the use of neuraminidase inhibitors in the treatment and prevention of influenza. Moreover, the current recommendations in European countries on the use of the neuraminidase inhibitors oseltamivir and zanamivir are appropriate and should be applied by prescribing physicians.
New and updated evaluations of neuraminidase inhibitors for preventing and treating influenza published
This evaluated patients admitted to hospital with laboratory-confirmed or clinically diagnosed influenza A H1N1pdm09 virus infection.
How effective were neuraminidase inhibitors during the 2009 pandemic?Archived
This systematic review and meta-analysis of observational data from an established group of specialists assessed treatment outcomes for all three neuraminidase inhibitors (NAIs); oseltamivir, zanamivir and peramivir given to hospitalised patients with influenza A(H1N1)pdm09 during the 2009 pandemic.
Facemasks and good hand hygiene to reduce influenza transmission in households – Cluster Randomised Controlled Trial in GermanyArchived
Facemasks and good hand hygiene to reduce influenza transmission in households – Cluster Randomised Controlled Trial in Germany
New (Post Pandemic 2009) UK Influenza Pandemic Preparedness StrategyArchived
Following an earlier consultation document issued in March 2011 the UK’s Secretary of State for Health, along with the UK’s developed administrations (N. Ireland, Scotland and Wales) published a new influenza pandemic strategy on 10 November.
Global estimates of the direct burden of influenza on the health of younger children (under age 5 years) including separate estimates for the European RegionArchived
It is accompanied by an editorial comment from Maria Zambon of the UK Health Protection Agency add link pleaseThis comprehensive study published by an international group attempts to estimate the global incidence of lower respiratory infections and premature deaths associated with influenza in children younger than 5 years.
WHO announcement of recommended strains to be included in the Southern Hemisphere 2012 influenza vaccine compositionArchived
The World Health Organization (WHO) recently recommended using the same three flu strains in next year's Southern Hemisphere (SH) vaccine as are in the current Northern Hemisphere vaccine and were used last year in southern hemisphere countries.
Recent findings about the clinical consequences of the 1918 pandemic – two further studies describing male autopsy results and female birth rate decline and miscarriagesArchived
The 1918 pandemic continues to provide a rich source of studies of the clinical impact of those novel viruses which between 1918 and 1920 killed up to 50 million people world-wide. These two recent studies first shows autopsy results among military recruits who died from the first influenza pandemic of the 20th century and the second suggests the impact on births.